(MedPage Today) -- The FDA has expanded the indication for several cardiac resynchronization therapy devices made by Medtronic to include patients with atrioventricular block and milder heart failure. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment